tert-Butyl 3-oxo-1-oxa-4,8-diazaspiro[5.5]undecane-8-carboxylate

Catalog No.: 
ACVNKT960
CAS No.: 
1934372-73-2
Molecular Formula: 
C13H22N2O4
Molecular Weight: 
270.33
tert-Butyl 3-oxo-1-oxa-4,8-diazaspiro[5.5]undecane-8-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$317.00InquiryInquiry
100mg98%$465.00InquiryInquiry
250mg98%$654.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-oxo-1-oxa-4,8-diazaspiro[5.5]undecane-8-carboxylate
IUPAC Nametert-butyl 3-oxo-1-oxa-4,8-diazaspiro[5.5]undecane-8-carboxylate
Molecular FormulaC13H22N2O4
Molecular Weight270.33
SMILESO=C(N(CCC1)CC1(OC2)CNC2=O)OC(C)(C)C
InChI KeySWVULFQUPHTWBI-UHFFFAOYSA-N
Synonymtert-butyl 3-oxo-1-oxa-4,8-diazaspiro[5.5]undecane-8-carboxylate;1-Oxa-4,8-diazaspiro[5.5]undecane-8-carboxylic acid, 3-oxo-, 1,1-dimethylethyl ester
CAS No.1934372-73-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVNKT960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVNKT960 route product structure diagram
    ACVNKT9601934372-73-2
Inquiry

2. ACVNKT960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVNKT960 route product structure diagram
    ACVNKT9601934372-73-2
Inquiry

3. ACVNKT960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVNKT960 route product structure diagram
    ACVNKT9601934372-73-2
Inquiry

Comments (0)